HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.

Abstract
Postoperative nausea and vomiting (PONV) is a frequent complication of surgery. Guidelines recommend using a 5-HT3 receptor antagonist (eg, ondansetron, dolasetron, granisetron) combined with a second agent (eg, dexamethasone) for patients at moderate to high risk for PONV. Although all 5-HT3 antagonists are effective, ondansetron and granisetron have been found to be effective at substantially lower doses than those approved by the US Food and Drug Administration. Metabolism of granisetron differs from metabolism of other 5-HT, antagonists, so it is less likely to adversely interact with other medications. This article explains the clinical pharmacology of 5-HT3 antagonists and provides recommendations for nursing management of PONV.
AuthorsThomas Board, Rhonda Board
JournalAORN journal (AORN J) Vol. 83 Issue 1 Pg. 209-16, 219-20 (Jan 2006) ISSN: 0001-2092 [Print] United States
PMID16528908 (Publication Type: Journal Article, Review)
Chemical References
  • Antiemetics
  • Indoles
  • Isoquinolines
  • Quinolizines
  • Quinuclidines
  • Serotonin 5-HT3 Receptor Antagonists
  • Serotonin Antagonists
  • Ondansetron
  • Palonosetron
  • Dexamethasone
  • dolasetron
  • Granisetron
Topics
  • Adult
  • Algorithms
  • Antiemetics (pharmacology, therapeutic use)
  • Child
  • Dexamethasone (therapeutic use)
  • Drug Administration Schedule
  • Drug Monitoring (nursing)
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Granisetron (therapeutic use)
  • Humans
  • Indoles (therapeutic use)
  • Isoquinolines (therapeutic use)
  • Nurse's Role
  • Nursing Assessment
  • Ondansetron (pharmacology, therapeutic use)
  • Operating Room Nursing (organization & administration)
  • Palonosetron
  • Patient Selection
  • Postoperative Nausea and Vomiting (etiology, nursing, physiopathology, prevention & control)
  • Practice Guidelines as Topic
  • Quinolizines (therapeutic use)
  • Quinuclidines (therapeutic use)
  • Risk Assessment
  • Risk Factors
  • Serotonin 5-HT3 Receptor Antagonists
  • Serotonin Antagonists (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: